Sodium Channel
Sodium channel are integral membrane proteins that form ion channels, conducting sodium ions (Na+) through a cell plasma membrane.
Products for Sodium Channel
- Cat.No. Product Name Information
- GC45985 (±)-Indoxacarb A broad-spectrum insecticide
-
GC30933
(+)-Kavain
An Analytical Reference Standard
- GC34952 (-)-Sparteine sulfate pentahydrate
- GC62739 (R)-Funapide (R)-Funapide ((R)-TV 45070) is the less active R-enantiomer of Funapide.
- GC35108 3-Deoxyaconitine 3-Deoxyaconitine a diterpenoid alkaloid, is a sodium channel activator.
-
GC42327
4,9-Anhydrotetrodotoxin
4,9-Anhydrotetrodotoxin (4,9-anhydro-TTX) is a derivative of TTX that selectively blocks inward sodium current through Nav1.6 voltage-activated sodium channels (IC50 = 7.8 nM in Xenopus oocytes).
- GC35147 5-(N,N-Hexamethylene)-amiloride An amiloride derivative with diverse biological activities
- GC65593 6-Benzoylheteratisine 6-Benzoylheteratisine is a naturally occurring antagonist of the Na+ channel activator aconitine.
- GC14481 A 887826 voltage-dependent Nav1.8 sodium channel blocker
- GC15701 A-803467 NaV1.8 channel blocker,potent and selective
- GC35273 Ajmaline
- GC30917 AM-2099 AM-2099 is a potent and selective inhibitor of voltage-gated sodium channel Nav1.7 with an IC50 of 0.16 μM for human Nav1.7.
- GC15458 Ambroxol HCl Ambroxol HCl (NA-872 hydrochloride), an active metabolite of the prodrug Bromhexine, has potent expectorant effects.
- GC31431 Amiloride (MK-870) Amiloride (MK-870) (MK-870) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]).
- GC17853 Amiloride HCl Amiloride HCl (MK-870 hydrochloride) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]).
- GC12051 Amiloride HCl dihydrate Amiloride HCl dihydrate (MK-870 hydrochloride dihydrate) is an inhibitor of both epithelial sodium channel (ENaC[1]) and urokinase-type plasminogen activator receptor (uTPA[2]).
- GC13723 Amitriptyline HCl Amitriptyline HCl is an inhibitor of serotonin reuptake transporter (SERT) and noradrenaline reuptake transporter (NET), with Kis of 3.45 nM and 13.3 nM for human SERT and NET, respectively.
- GC18203 Annonacin Annonacin is a potent and lipophilic acetogenin from A.
- GC65272 APETx2 TFA APETx2 TFA, a sea anemone peptide from Anthopleura elegantissima, is a selective and reversible ASIC3 inhibitor, with an IC50 of 63 nM.
- GC63799 AZ194 AZ194 is a first-in-class, orally active inhibitor of CRMP2-Ubc9 interaction and inhibitor of NaV1.7 (IC50=1.2 μM).
-
GC11693
Benzamil hydrochloride
Na+/Ca2+ exhanger (NCX) inhibitor
- GC13125 Benzocaine Sodium channel inhibitor
- GC25134 Benzocaine hydrochloride Benzocaine hydrochloride (Ethyl 4-aminobenzoate, Ethyl p-aminobenzoate) is a surface anesthetic that acts by preventing transmission of impulses along nerve fibers and at nerve endings.
- GC34486 BI 01383298 An NaCT inhibitor
- GC34492 BI-9627 An NHE1 inhibitor
- GC60642 Bifenthrin A synthetic pyrethroid insecticide
- GC64658 Bliretrigine Bliretrigine is a sodium channel blocker.
- GC42976 Brevetoxin B Brevetoxin B is a polyketide neurotoxin produced by Karenia species and other dinoflagellates.
- GC35568 Bulleyaconitine A Bulleyaconitine A is an analgesic and antiinflammatory drug isolated from Aconitum plants; has several potential targets, including voltage-gated Na+ channels.
- GC12410 Bupivacaine HCl Bupivacaine HCl is a NMDA receptor inhibitor.
- GC17340 Carbamazepine Inhibitor of neuronal voltage-gated Na+ channels
- GC17842 CARIPORIDE Potent NHE inhibitor
- GC30280 Chlorpromazine D6 hydrochloride An internal standard for the quantification of chlorpromazine
-
GC14216
Chlorpromazine HCl
dopamine receptor antagonist
- GC16182 Co 102862 voltage-gated sodium channel blocker
- GC47155 Cyfluthrin A pyrethroid insecticide
- GC15915 Dibucaine Local anesthetic
- GC16696 Dibucaine (Cinchocaine) HCl Sodium channel inhibitor
- GC35860 Dibucaine hydrochloride
- GC38484 Dimethyl lithospermate B Dimethyl lithospermate B (dmLSB) is a selective Na+ channel agonist.
- GC43478 Disopyramide Disopyramide is a sodium channel blocker that, in rabbit ventricular myocytes, binds and dissociates from open channels more quickly than from resting channels.
- GC35903 DSP-2230 DSP-2230 is a selective Nav1.7/Nav1.8 blocker.
-
GC15893
EIPA
EIPA inhibited TRPP3-mediated Ca2+-activated currents with IC50 values of 10.5 µM.
-
GC35970
EIPA hydrochloride
EIPA (L593754) hydrochloride is an orally active TRPP3 channel inhibitor with an IC50 of 10.5 μM.
- GC30063 Eleclazine hydrochloride (GS 6615 hydrochloride) Eleclazine (GS 6615) hydrochloride is a selective cardiac late sodium current inhibitor and a weak inhibitor of potassium current with IC50 value of <1 μM and approximately 14.2 μM, respectively.
- GC35993 Eniporide hydrochloride Eniporide hydrochloride (EMD-96785 hydrochloride) is a potent Na+/H+ exchange inhibitor.
- GC13809 Eslicarbazepine acetate antiepileptic drug
- GC15824 Ethyl 3-Aminobenzoate (methanesulfonate) Ethyl 3-Aminobenzoate (methanesulfonate) (MS-222) is common used to immobilize fish for marking or transport and to suppress sensory systems during invasive procedures.
- GC38389 Evenamide Evenamide (NW-3509) is an orally available voltage-gated sodium channel (VGSC) blocker (Ki=0.4 ?M) for the research of schizophrenia.
- GC65416 Flecainide Flecainide is a potent and orally active antiarrhythmic agent.
- GC15823 Flecainide acetate An inhibitor of cardiac late sodium current
- GC65150 Flecainide hydrochloride Flecainide hydrochloride is a potent and orally active antiarrhythmic agent.
- GC33895 FR183998 free base FR183998 free base is a potent Na+/H+-exchange inhibitor, with IC50s of 0.3 nM, 3.1 nM and 6.5 nM by measurement of pHi change in rat lymphocytes, rat and human platelets, respectively.
- GC30628 Funapide (TV 45070) Funapide (TV 45070) (TV 45070; XEN402) is a potent Sodium Channel Nav1.7 inhibitor.
- GC64206 GDC-0310 GDC-0310 is a selective acyl-sulfonamide Nav1.7 inhibitor, with an IC50 of 0.6 nM for hNav1.7.
- GN10799 Ginsenoside Rg3
- GC67949 GNE-0439
- GC31065 GNE-131 GNE-131 is a potent and selective inhibitor of human sodium channel NaV1.7, with an IC50 of 3 nM.
- GC36169 GNE-616 GNE-616 is a highly potent, metabolically stable, orally bioavailable, and subtype selective Nav1.7 inhibitor (Ki of 0.79 nM and Kd of 0.38 nM for hNav1.7) for the treatment of chronic pain.
- GC10830 GS967 inhibitor of cardiac late sodium current
- GC10234 GSK1014802(CNV1014802) GSK1014802(CNV1014802) (GSK-1014802) is a novel small molecule state-dependent sodium channel blocker; Nav1.7 sodium channel inhibitor.
- GC50707 GX 201 GX 201 is a selective NaV1.7 inhibitor, with an IC50 of <3.2 nM for hNaV1.7.
- GC39792 Halazone Halazone is an atypical antimicrobial sulfonamide derivative and a carbonic anhydrase II inhibitor with a Kd value of 1.45 ?M.
- GC65531 Hardwickiic acid Hardwickiic acid ((-)-Hardwikiic acid) is an antinociceptive compound that blocks Tetrodotoxin-sensitive voltage-dependent sodium channels.
- GC12806 Huwentoxin IV NaV1.7 channel blocker
- GC15860 Ibutilide Fumarate Class III antiarrhythmic agent
- GC17395 ICA 121431 human NaV1.3 and NaV1.1 channels inhibitor
- GC10836 Jingzhaotoxin III NaV1.5 channels blocker
- GC16786 KC 12291 hydrochloride voltage-gated sodium channel blocker
- GC14764 Lamotrigine 5-HT inhibitor, sodium channel blocker
- GC64113 Lamotrigine-13C3,d3
- GC15978 Levobupivacaine HCl Levobupivacaine HCl ((S)-(-)-Bupivacaine monohydrochloride) is a long-acting amide local anaesthetic.
- GC13505 Licarbazepine voltage-gated sodium channel blocker
- GC17608 Lidocaine Anasthetic and class Ib antiarrhythmic agent
- GC33831 Lidocaine hydrochloride (Lignocaine hydrochloride) Lidocaine hydrochloride (Lignocaine hydrochloride) (Lignocaine hydrochloride) inhibits sodium channels involving complex voltage and using dependence.
- GC61594 Lu AE98134 Lu AE98134, an activator of voltage-gated sodium channels, acts as a partly selective Nav1.1 channels positive modulator.
- GC63063 Mebeverine hydrochloride
- GC41540 Mepivacaine Mepivacaine is an analytical reference standard that is categorized as an anesthetic.
- GC10224 Mepivacaine HCl Mepivacaine HCl binds to specific voltage-gated sodium ion channels in neuronal cell membranes, which inhibits both sodium influx and membrane depolarization.
- GC34665 Metaflumizone Metaflumizone is a semicarbazone insecticide, acts as a potent sodium channel blocker.
- GC61046 Methocarbamol D5 An internal standard for the quantification of methocarbamol
- GC11069 Meticrane Peripheral-type benzodiazepine receptor (PBR) inhibitor
- GC44189 Mexiletine (hydrochloride) Mexiletine is a voltage-gated sodium channel blocker and class Ib antiarrhythmic agent that preferentially binds to open/inactive channels.
- GC39618 Mexiletine D6 hydrochloride Mexiletine D6 hydrochloride (KOE-1173-d6 hydrochloride) is a deuterium labeled Mexiletine hydrochloride (KOE-1173 hydrochloride).
- GC36648 Moricizine
-
GC31200
Myomodulin
Myomodulin is a neuropeptide present in molluscs, insects, and gastropods.
- GC65231 N-Bromoacetamide N-Bromoacetamide can irreversibly remove sodium channel inactivation in the cytoplasmic face of the membrane, also decreasing K current rapid inactivation.
- GC50071 NAV 26 Selective Nav1.7 channel blocker
- GC61110 Nav1.1 activator 1 Nav1.1 activator 1 (compound 4), a highly potent Nav1.1 activator with BBB penetration, increases decay time constant (tau) of Nav1.1 currents at 0.03 μM along with significant selectivity against Nav1.2, Nav1.5, and Nav1.6.
- GC36697 Nav1.7 inhibitor Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor.
- GC36698 NaV1.7 inhibitor-1 NaV1.7 inhibitor-1 is an efficacious voltage-gated sodium channel (NaV) 1.7 inhibitor with an IC50 of 0.6 nM for hNaV1.7, exhibits 80-fold selectivity versus hNaV1.5.
- GC31002 Nav1.7-IN-2 Nav1.7-IN-2 is an inhibitor of voltage-gated sodium channels (Nav), in particular Nav 1.7, with IC50 of 80 nM.
- GC65320 Nav1.7-IN-3 Nav1.7-IN-3 is a selective, orally bioavailable voltage-gated sodium channel Nav1.7 inhibitor with an IC50 of 8 nM.
- GC64072 NBI-921352
- GC31302 NHE3-IN-1 NHE3-IN-1 is a sodium/proton exchanger type 3 (NHE-3) inhibitor extracted from patent WO 2011019784 A1.
- GC63108 NHE3-IN-2 NHE3-IN-2 is a Na+/H+ exchanger-3 (NHE3) inhibitor ( patent WO2001079186A1, example 6-Chlor-4-phenyl-2-chinazolinyl-guanidin).
- GC31216 Nicainoprol (RU-42924) Nicainoprol (RU-42924) is a fast-sodium-channel blocking drug, which is a potent antiarrhythmic agent.
-
GC39719
Nigericin
K+/H+ ionophore,promoting K+/H+ exchange across mitochondrial membrane
- GC50299 OD1 Potent hNav1.4, rNav1.6 and rNav1.7 channel activator
- GC10500 Oxcarbazepine BTX inhibitor